• Brefeldin A: ATPase Inhibitor Revolutionizing Vesicle Tra...

  2025-10-01

  Brefeldin A (BFA) delivers unmatched precision as an ATPase inhibitor and vesicle transport disruptor, empowering researchers to dissect protein trafficking and ER stress in cancer and endothelial systems alike. Its robust, reproducible effects make it a cornerstone for analyzing apoptosis, migration, and stress signaling, particularly in challenging translational models.

• Cy3 TSA Fluorescence System Kit: Advancing Transcriptiona...

  2025-09-30

  Explore how the Cy3 TSA Fluorescence System Kit leverages tyramide signal amplification to enable advanced detection of transcriptional and lipogenic pathway alterations in cancer. This in-depth article uniquely connects fluorescence amplification technology to the molecular study of de novo lipogenesis and transcriptional regulation, offering actionable insight beyond conventional applications.

• 5-Ethynyl-2'-deoxyuridine (5-EdU): Precision Tools for S ...

  2025-09-29

  Discover the advanced mechanisms and unique advantages of 5-Ethynyl-2'-deoxyuridine (5-EdU) for click chemistry cell proliferation detection. This article uniquely explores 5-EdU’s role in high-fidelity S phase DNA synthesis analysis and its transformative impact on stem cell and reproductive biology.

• EZ Cap™ Human PTEN mRNA (ψUTP): Redefining mRNA Therapeut...

  2025-09-28

  Explore the scientific foundations and translational potential of EZ Cap™ Human PTEN mRNA (ψUTP), a human PTEN mRNA with Cap1 structure, for cancer research and mRNA-based gene expression studies. This article uniquely dissects mechanistic advances, clinical implications, and future directions beyond existing content.

• Rucaparib (AG-014699): Precision Radiosensitizer Targetin...

  2025-09-27

  Explore how Rucaparib (AG-014699, PF-01367338), a potent PARP inhibitor, uniquely enables advanced DNA damage response research and radiosensitization in PTEN-deficient and ETS fusion-expressing cancer models. This article unveils new mechanistic links between DNA repair inhibition and transcription-coupled cell death, offering a distinct perspective for cancer biology research.

• Next-Gen mRNA Tools: EZ Cap Cy5 Firefly Luciferase mRNA f...

  2025-09-26

  Discover how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) revolutionizes mammalian gene expression with Cap1 capping, 5-moUTP modification, and Cy5 fluorescence. This article offers unique mechanistic insights and advanced applications in translation efficiency, imaging, and immune modulation.

• ABT-737 and RNA Pol II: Integrating BCL-2 Inhibition with...

  2025-09-25

  Explore how the BCL-2 protein inhibitor ABT-737 intersects with newly discovered RNA Pol II-dependent apoptosis pathways, revealing advanced strategies for targeted cancer research. This article provides a unique synthesis of mechanistic, translational, and experimental insights.

• VX-765: Advanced Caspase-1 Inhibitor Applications in Cell...

  2025-09-24

  Explore how VX-765, a selective caspase-1 inhibitor, redefines approaches to inflammatory cytokine modulation and cell death pathways. This article provides a unique synthesis of VX-765’s mechanistic action, integration with novel apoptotic insights, and its transformative role in translational research.

• Murine RNase Inhibitor: Advancing RNA Stability for Circu...

  2025-09-23

  Explore the unique oxidative stability and specificity of Murine RNase Inhibitor, a recombinant protein essential for RNA degradation prevention in advanced molecular biology assays, including applications in cutting-edge circular RNA vaccine research.

• The fat body is one

  2025-03-03

  

  The fat body is one of the largest tissues of Bombyx mori, with components including fat, glycogen, protein and vitamins. The fat body exhibits important physiological functions, not only storing a large number of nutrients but also serving as an important site of biosynthesis and metabolism (Arrese

• br Does TIPARP contribute to the diverse

  2025-03-03

  

  Does TIPARP contribute to the diverse species sensitivity to TCDD toxicity? In chick embryo hepatocytes TIPARP was reported to mediate the TCDD-dependent suppression of hepatic gluconeogenesis, by reducing cellular NAD+ levels and reducing PCK1 expression, suggesting that ADP-ribosylation enhance

• The results of cell culture models were further supported

  2025-03-03

  

  The results of cell culture models were further supported by in vivo studies in mice treated with PXR and/or AhR agonists, PCN and β-NF. In these mice, AhR-regulated cyp1a1, and cyp1a2 were suppressed by PXR activation as determined by real time Q-PCR (Fig. 3). The level of PXR mRNA was not changed

• Given the powerful and ubiquitous nature

  2025-03-03

  

  Given the powerful and ubiquitous nature of adenosine action within the CNS, basal levels of extracellular adenosine are carefully regulated and are estimated to be in the region of 30–300 nM (Fredholm et al., 2001). The two main pathways for the control of extracellular adenosine involve phosphoryl

• br Discussion Mycobacterium tuberculosis infection is a

  2025-03-03

  

  Discussion Mycobacterium tuberculosis infection is a main threat to mankind, with one third of the world population being infected. [9] Over nine million new cases of tuberculosis and two million deaths from this disease occur yearly worldwide. [10] The rising incidence of tuberculosis over the l

• Phorbol 12,13-dibutyrate br Thymic expression of AChR

  2025-03-03

  

  Thymic expression of AChR Both linear unfolded epitopes of AChR subunits and the intact AChR are avidly expressed in thymus, particularly by thymic epithelial cells and myoid cells [17], [18], [19]. AChR-antibody positive MG patients often show thymic hyperplasia, characterized by lymphoid follic

15244 records 5/1017 page Previous Next 12345 下5页 Last page